BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Khoury T, Sbeit W, Napoléon B. Endoscopic ultrasound guided radiofrequency ablation for pancreatic tumors: A critical review focusing on safety, efficacy and controversies. World J Gastroenterol 2023; 29(1): 157-170 [PMID: 36683710 DOI: 10.3748/wjg.v29.i1.157]
URL: https://www.wjgnet.com/1948-5182/full/v29/i1/157.htm
Number Citing Articles
1
Tawfik Khoury, Wisam Sbeit, Pietro Fusaroli, Davide Campana, Nicole Brighi, Bertrand Napoleon, Andrea Lisotti. Safety and efficacy of endoscopic ultrasound‐guided radiofrequency ablation for pancreatic neuroendocrine neoplasms: Systematic review and meta‐analysisDigestive Endoscopy 2024; 36(4): 395 doi: 10.1111/den.14681
2
Alejandra Vargas, Priyata Dutta, Eileen S. Carpenter, Jorge D. Machicado. Endoscopic Ultrasound-Guided Ablation of Premalignant Pancreatic Cysts and Pancreatic CancerDiagnostics 2024; 14(5): 564 doi: 10.3390/diagnostics14050564
3
Zoé Debraine, Ivan Borbath, Pierre Deprez, Florence Bosly, Dominique Maiter, Raluca M. Furnica. Long‐term clinical and radiological outcomes of endoscopic ultrasound‐guided radiofrequency ablation of benign insulinomasClinical Endocrinology 2023;  doi: 10.1111/cen.14981
4
Ye-Cheng Xu, De-Liang Fu, Feng Yang. Unraveling the enigma: A comprehensive review of solid pseudopapillary tumor of the pancreasWorld Journal of Gastrointestinal Oncology 2024; 16(3): 614-629 doi: 10.4251/wjgo.v16.i3.614
5
Elias Karam, Alexandra Nassar, Sara Elkurdi, Guillaume Péré, Thomas Freville, Edouard Wasielewski, Anaïs Palen, Julie Périnel, Jean-Christophe Lifante, Emilie Lermite, Ugo Marchese, Mustapha Adham, Olivier Turrini, Laurent Sulpice, Nicolas Régenet, Nicolas Carrère, Sébastien Gaujoux, François Pattou, Alain Sauvanet. Enucleation for Sporadic Nonfunctioning Pancreatic Neuroendocrine Tumors Larger than 2 Centimeters Is Associated with Equivalent Morbidity and Survival Compared to Smaller Tumors: A Multi-Institutional StudyNeuroendocrinology 2024; : 1 doi: 10.1159/000541078
6
Tom G. Moreels. How to implement adverse events as a quality indicator in gastrointestinal endoscopyDigestive Endoscopy 2024; 36(1): 89 doi: 10.1111/den.14641
7
Bertrand Napoléon, Andrea Lisotti, Fabrice Caillol, Mohamed Gasmi, Philippe Ah-Soune, Arthur Belle, Antoine Charachon, Franck Cholet, Pierre-Yves Eyraud, Philippe Grandval, Jean-Michel Gonzalez, Francois Habersetzer, Stéphane Koch, Marc Le Rhun, Luigi Mangialavori, Nicolas Musquer, Maxime Palazzo, Laurent Poincloux, Jocelyn Privat, Adrien Sportes, Morgane Stouvenot, Clement Subtil, Lucie Thomassin, Geoffroy Vanbiervliet, Guillaume Vidal, Lucine Vuitton, Marc Giovannini, Marc Barthet. Risk factors for EUS-guided radiofrequency ablation adverse events in patients with pancreatic neoplasms: a large national French study (RAFPAN study)Gastrointestinal Endoscopy 2023; 98(3): 392 doi: 10.1016/j.gie.2023.04.003
8
Vishali Moond, Bhumi Maniyar, Prateek Suresh Harne, Jennifer M. Bailey-Lundberg, Nirav C. Thosani. Harnessing endoscopic ultrasound-guided radiofrequency ablation to reshape the pancreatic ductal adenocarcinoma microenvironment and elicit systemic immunomodulationExploration of Targeted Anti-tumor Therapy 2024; 5(5): 1056 doi: 10.37349/etat.2024.00263
9
V. V. Lozovaya, O. A. Malikhova, A. S. Vodoleev, O. A. Gusarova, A. O. Tumanyan, A. G. Malikhov. Endoscopic radiofrequency ablation under the control of ultrasonography as a new method of treatment of neuroendocrine pancreatic tumors and analgesia option for locally advanced forms of pancreatic cancer. First experience in RussiaSurgery and Oncology 2023; 13(3): 11 doi: 10.17650/2949-5857-2023-13-3-11-20
10
Carlos Robles-Medranda, Raquel Del Valle, Miguel Puga-Tejada, Martha Arevalo-Mora, Domenica Cunto, Maria Egas-Izquierdo, Lorena Estrada-Guevara, Orlando Bunces-Orellana, Daniel Moreno-Zambrano, Juan Alcivar-Vasquez, Haydee Alvarado-Escobar, Ruxandra C. Merfea, Jonathan Barreto-Perez, Jorge Rodriguez, Daniel Calle-Loffredo, Hannah Pitanga-Lukashok, Jorge Baquerizo-Burgos, Daniela Tabacelia. Assessing EUS-guided radiofrequency ablation in unresectable pancreatic ductal adenocarcinoma: a single-center historic cohort studyGastrointestinal Endoscopy 2024; 100(2): 250 doi: 10.1016/j.gie.2024.03.023
11
Joan B. Gornals. EUS-guided radiofrequency ablation in pancreatic cancer: Promising but still questionable!Gastrointestinal Endoscopy 2024; 100(2): 259 doi: 10.1016/j.gie.2024.04.022
12
Kerui Pan, Sisi Wang, Xueping Li, Shuoming Wu, Ashraf Elbahrawy. Efficacy and safety of ultrasound-guided radiofrequency ablation combined with transhepatic artery embolization chemotherapy for hepatocellular carcinoma: A meta-analysisPLOS ONE 2024; 19(9): e0305965 doi: 10.1371/journal.pone.0305965
13
Toufic Kachaamy. Top 10 tips for performing cancer ablationGastrointestinal Endoscopy 2024; 100(2): 292 doi: 10.1016/j.gie.2024.03.007
14
Sahib Singh, Vishnu Charan Suresh Kumar, Douglas G. Adler. EUS–radiofrequency ablation for pancreatic neuroendocrine tumors: is there a promising future?Endoscopic Ultrasound 2024;  doi: 10.1097/eus.0000000000000083